Physician profile
Michael Faherty Foster
NPI 1699067751
$3,114.36
in general payments reported to CMS, 2019-2025
19 companies · $845 in 2025
The $845 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $236 · 2021: $318 · 2022: $315 · 2023: $203 · 2024: $225 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,122.19 | 2019-2025 | Medline Industries, INC., Xpress Loprofile |
| Intersect Ent, INC. | $392.96 | 2019 | |
| Medtronic, INC. | $348.13 | 2021-2025 | Nuvent, Stealthstation S8 Platform, Nim Vital |
| Advanced Bionics, LLC | $269.88 | 2020-2022 | |
| Acclarent, INC | $210.96 | 2019-2021 | |
| Integra Lifesciences Corporation | $195.80 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Medtronic USA, INC. | $154.09 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $97.08 | 2021-2023 | Dupixent |
| Cochlear Americas | $62.30 | 2019 | |
| Glaxosmithkline, LLC. | $48.73 | 2021-2023 | Nucala |
| Karl Storz Endoscopy-America | $43.94 | 2019-2022 | |
| Olympus America INC. | $30.94 | 2019-2021 | |
| Inspire Medical Systems, INC. | $29.46 | 2024 | Inspire |
| Neurent Medical Limited | $26.79 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Genzyme Corporation | $22.73 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $17.26 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.91 | 2019 | |
| Kaleo, INC. | $13.78 | 2019 | |
| Aerin Medical INC. | $13.43 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.